PATH

11/28/2025

In Kenya’s Nyamira County, HIV and tuberculosis are major health challenges. PATH partnered with local leaders to strengthen community health services—training and equipping frontline workers, improving data systems, and expanding access to care.

In 2024, over 114,000 people were screened for TB. The effort is now a model for advancing universal health coverage.

PATH: The way to better health.

11/27/2025

One dose. Huge impact. 💉🌍

PATH research helped prove a single HPV shot can protect girls from cervical cancer—changing global policy and making vaccines more accessible.

Make a gift to PATH this to help us reach more girls with this lifesaving vaccine. Because every girl deserves a healthy future. https://bit.ly/4pffxuJ

11/26/2025

Digging beyond the stats to discover what really blocks immunization:

In Zambia, PATH’s Living Labs worked hand-in-hand with caregivers, health workers, and communities to uncover the hidden barriers to . From mistrust and cultural norms to logistical hurdles, listening first helped design solutions that actually reach children who need vaccines most.

This is human-centered design in action—co-creating solutions with the people who know the challenges best.

Read the full story: https://bit.ly/46V4yR6

In Zambia, too many children under five still miss lifesaving vaccines against measles-rubella, polio, and more, putting them at risk for preventable disease and death.

11/25/2025

Join us on Wednesday, December 3, for the last of 2025! 🦟

Interventions that reduce mosquito populations and prevent bites are an essential part of malaria control & elimination, but challenges—like growing insecticide resistance and climate change—require new tools.

Supported by an unrestricted educational grant from GSK Global Health, this session will feature speakers from Target Malaria, PATH, and CRID Cameroon. Together we'll explore the successful approaches and lessons learned from rolling out new vector control innovations in the communities hit hardest by malaria.

Register: https://path.zoom.us/webinar/register/WN_IQxmCM26RU-8sW39FPR4kA #/registration

11/25/2025

Congratulations to the County First Ladies Association (CFLA) on the launch of their 2025–2028 Strategic Plan!

The CFLA brings together the spouses of Kenya’s 47 county governors, who champion health, early childhood development, gender equity, and community well-being. PATH is proud to have partnered with CFLA over the past two years through our Center for Advocacy & Policy to co-develop this transformative strategy and strengthen advocacy capacity.

The new plan focuses on areas that matter most to families and communities across Kenya, including health, economic empowerment, and mentorship and leadership for youth, among others. At PATH, we’re especially proud of the plan’s strong focus on .

11/24/2025

In Rachuonyo North, Kenya, community leader Jacob Aduda and PATH’s team are using human-centered design to reach zero-dose children—those who have never received a vaccine—and rebuild trust between health workers and families.

By listening first and co-creating solutions, they’re showing how empathy and collaboration drive real health impact. Through interventions like Chanjo Talks Kazini, which engages male caregivers, they are addressing hidden barriers, refining strategies based on feedback, and seeing communities come together for better care.

Read Jacob’s story: https://bit.ly/3KURbrq

11/21/2025

Imagine a world where children no longer face the threat of polio. Thanks to decades of global health progress, that dream is now within reach.

PATH helped lead the creation of a next-gen oral polio vaccine—already used in 2+ billion doses.

Together, we can finish the job. Be the way to better health for millions by supporting PATH this , December 2: https://bit.ly/4pffxuJ

11/20/2025

Can AI safely support mental health? In a special episode of This Week in Global Development, PATH's Bilal Mateen joins Sahpra's Christelna Reynecke and Wellcome Trust's Miranda Wolpert to discuss how AI can help address the global gap.

Together with Devex Senior Editor Catherine Cheney, they explore the promise of to expand access to care—and the regulations required to make that promise real while keeping patients safe.

🎧: https://www.devex.com/news/this-week-in-global-development-106893
🎬: https://www.youtube.com/watch?v=bJ5UsQMD6sM

In this special episode of the This Week in Global Development podcast, we dive into a fast-moving and timely question at the intersection of technology and ...

11/20/2025

Conflict in Ethiopia’s Afar Region shut down vital health services, leaving families without care. PATH and Gavi, the Vaccine Alliance helped restore 14 clinics, bringing health services back to 70,000 people. With community support and renovated facilities, families now access lifesaving care—symbolizing resilience, healing, and PATH’s commitment to reaching everyone, everywhere.

PATH: The way to better health.

11/19/2025

If we can’t talk about diarrhea, we can’t defeat it. We launched the DefeatDD initiative 15 years ago to raise awareness about and its solutions, like vaccines and access to clean water & safe toilets.

Since 2000, thanks to the tireless work of many partners, child deaths from diarrhea have dropped by over 70%—a number that makes us *flush* with pride and confident in the momentum ahead.

Read the DefeatDD case study: https://bit.ly/4nYQk6P

11/18/2025

💉 The November edition of PATH Insights is out now. This month, we talk about PATH's role in the big push to , plus projects in Southeast Asia and prevention amid the war in Ukraine.

Read now & subscribe to get the next issue in your inbox: https://bit.ly/4kWKvFN

11/17/2025

Typhoid remains a significant public health threat in many parts of the world, particularly where access to safe water, sanitation, and hygiene infrastructure are a challenge.

We can prevent typhoid with —but to ensure sustainable access, we need more of them.

That’s why PATH supported a Phase 3 study of the new EuBiologics Co., Ltd. typhoid conjugate vaccine, which found that the vaccine is safe and capable of prompting a strong immune response in typhoid-endemic populations in sub-Saharan Africa. These results are pivotal for demonstrating the vaccine meets the international safety and quality standards necessary for global use.

Read more: https://bit.ly/4nPL8SF

Phase 3 results from a trial of a new typhoid conjugate vaccine show positive results, offering the potential for an additional product to increase access.